Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
Inhibition of hepatic drug metabolism in the rat after Corynebacterium parvum treatment.
复制标题
小棒状杆菌治疗后大鼠肝脏药物代谢的抑制。
DOI:
10.1016/0006-2952(83)90282-4
复制
发表时间:
1983
影响因子:
5.8
通讯作者:
Loo,TL
中科院分区:
文献类型:
--
作者:
Farquhar,D;Benvenuto,JA;Kuttesch,N;Loo,TL
Drug-metabolizing enzyme activities, cytochrome concentration, and protein content of hepatic microsomal preparations from adult, female Sprague-Dawley rats were examined at 1-, 3-, 6-, 10-, 14- and 17-day intervals after administration of a single intravenous injection ofCorynebacterium parvum(C. parvum) at a dose of 10 mg/m2. Aniline hydroxylase (AH) activity, aminopyrine demethylase (APD) activity, and cytochrome P-450 concentration were reduced 20–50% on days 3–6 and, thereafter, gradually recovered to control levels by day 17. Cytochromecreductase activity and cytochromeb5concentration were reduced significantly (24%) only on day 10. Microsomal protein concentration was unchanged.C. parvumaddedin vitrohad no effect on AH or APD activity. Although livers of treated rats were only slightly (< 20%) enlarged, gross splenomegaly was apparent, reaching a maximum on day 6. A marked inverse correlation existed between the temporal variation in the size of the spleen and APD activity. In rats killed 6 days after administration ofC. parvumat 0.67 to 10.00 mg/m2, a direct relationship was apparent between the adjuvant dose and the magnitude of reduction of APD activity. A similar relationship was apparent between splenomegaly and APD activity. Histopathologic examination of liver sections from treated rats revealed numerous granulomas throughout the parenchyma. The magnitude of enzyme inhibition generally paralleled the severity of the hepatic lesions.